Trials have shown that prostate-specific membrane antigen (PSMA)-based positron emission tomography/computed tomography (PET/CT) is more accurate than conventional imaging for staging of nodal status in prostate cancer. We discuss the advantages of PSMA PET/CT over current options for nodal staging and highlight the issues that need to be resolved for implementation of this modality in routine practice.
European urology. 2024 Dec 18 [Epub ahead of print]
Johan Stranne, Ann Henry, Daniela E Oprea-Lager, EAU-EANM-ESTRO-ESUR-ISUP-SIOG Prostate Cancer Guidelines Panel
Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden., University of Leeds and Leeds Teaching Hospital, Leeds, UK., Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.